🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Enterobacteriaceae Infections

Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children NCT04535661n/a1 site📍 Shanghai Children's Hospital of Fudan University A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites📍 Lenexa📍 Secaucus📍 Rochester GlaxoSmithKline · Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediu… Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia. NCT07086391n/a1 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Polymyxin B Sulfate 25mg Jet Nebulization / Vibrating Mesh Nebulization FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae NCT04759001Phase 1, Phase 21 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Donor FMT, Placebo FMT Study of E. Coli Isolates From Recurrent Urinary Tract Infections NCT05826067n/a1 site📍 Brussels Université Catholique de Louvain · Tests: collection of bacterial strains Epidemiology and Overtime Genomic Evolution of Klebsiella Pneumoniae and Enterobacter Cloacae Complex (ECC) in Stools of ICU's Patients NCT07744321n/a1 site📍 Caen University Hospital, Caen Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial NCT06080698NA11 sites📍 San Francisco📍 Denver📍 Baltimore Johns Hopkins University · Tests: Intravenous Antibiotics, Oral Antibiotics Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children NCT03825874n/a20 sites📍 Charenton-le-Pont📍 Chennevières-sur-Marne📍 Combs-la-Ville Centre Hospitalier Intercommunal Creteil · Tests: Amikacin, usual antibiotic treatment EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics NCT05979545Phase 421 sites📍 Vellore📍 George Town📍 Ipoh National University of Singapore · Tests: Rapid Diagnostics A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults NCT07663032Phase 11 site📍 Bloemfontein GlaxoSmithKline · Tests: Pan-Salmonella-with-Alum (Low dose) vaccine, Pan-Salmonella-with-Alum (Full dose) vaccine, Pan-Salmonella-without-Alum … Transmission of ESBL-producing Enterobacteriaceae NCT03465683n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: ESBL-producing Enterobacteriaceae Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals NCT05871476NA1 site📍 Thái Bình Hanoi University of Public Health · Tests: Hospital Cohort Care Intervention at the hospital, , Household Education Communication Hygiene Intervention, Livestock … Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit NCT05475574NA1 site📍 Metz Centre Hospitalier Régional Metz-Thionville · Tests: Discontinuation of contact precautions for ESBLE Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria NCT07345923n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old NCT07049159Phase 21 site📍 Baltimore Eveliqure Biotechnologies GmbH · Tests: ShigETEC vaccine, Placebo, Challenge: Shigella flexneri 2457T at a dose of 1.5x10^3 CFU Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection NCT05219110NA26 sites📍 Birmingham📍 Little Rock📍 La Jolla University of Calgary · Tests: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenanc… Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora NCT05153824n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment NCT04846803NA2 sites📍 Aarhus N📍 Odense C Odense University Hospital · Tests: ABU bladder lavage, Saline bladder lavage Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria NCT06559618Phase 12 sites📍 St Louis📍 Houston Barbara Trautner · Tests: Phage Therapy, Placebo A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) NCT05488340Phase 217 sites📍 Fresno📍 Lancaster📍 Los Angeles Locus Biosciences · Tests: LBP-EC01 0.1 x IV dose, LBP-EC01 0.01x IV Dose, LBP-EC01 IV Infusion Dose, Placebo, LBP-EC01 Aztreonam-Avibactam in Immunocompromised Hosts NCT07890480n/a1 site📍 Buenos Aires Centro de Educación Medica e Investigaciones Clínicas Norbe… · Tests: Aztreonam-Avibactam, Ceftazidime-Avibactam Plus Aztreonam International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections NCT06634940n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant NCT06938867Phase 1, Phase 210 sites📍 Duarte📍 San Francisco📍 Baltimore SNIPR Biome Aps. · Tests: SNIPR001 consists of genetically modified bacteriophages specifically targeting Escherichia coli, Placebo 10 mL A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants NCT07286370Phase 21 site📍 Banjul GlaxoSmithKline · Tests: Low dose of iNTS-TCV, Full dose of iNTS-TCV, TYPHIBEV, Prevenar 13, Nimenrix Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection NCT06051513NA15 sites📍 Hefei📍 Hefei📍 Jinjiang Southeast University, China · Tests: treatment with or without colistin First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults NCT07205926Phase 11 site📍 Cincinnati Inventprise Inc. · Tests: IVT Shigella-04, Placebo (0.9% saline) Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections NCT07089186Phase 31 site📍 Shanghai Qilu Pharmaceutical Co., Ltd. · Tests: Meropenem and Pralurbactam, Best Available Therapy (e.g., colistin, meropenem, tegecycline, amikacinceftezidime-avibata… Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria NCT06910878n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Further MT for Antibiotic-Resistant Bacterial Colonization NCT05835206Phase 26 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Microbiome Therapeutic, Placebo NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy